Back to search results

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoblastic Leukemia, Acute, Childhood · Lymphoblastic Leukemia · Lymphoblastic Leukemia, Acute Adult · Lymphoblastic Leukemia in Children · CAR · CAR T-Cell-Related Encephalopathy Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Allen Yeoh Eng Juh, Singapore, Singapore

    Contact: Study coordinator (Allen Yeoh, M.D) · paeyej@nus.edu.sg · (+65) 6772 2002
    Contact: Study coordinator (Zhiwei Chen, BSc.) · chen.zhiwei@nus.edu.sg · (+65) 6772 4406
    Bernice Oh, M.D (Sub-investigator)
    Noriko Shimasaki, M.D, PhD (Sub-investigator)
    Michelle Poon, M.D (Sub-investigator)
    Esther Chan, M.D (Sub-investigator)
    Elaine Coustan-Smith, MS (Sub-investigator)
Study leads

  • Allen Yeoh, M.D

    Principal Investigator

    National University Hospital, Singapore

  • Dario Campana, M.D, PhD

    Study Director

    National University of Singapore

View source on ClinicalTrials.gov(opens in a new tab)